International Immunology, Vol. 16, No. 2, pp. 241-247,
February 2004
© 2004 Japanese Society for Immunology
Down-regulation of the invariant V
14 antigen receptor in NKT cells upon activation
1 RIKEN Research Center for Allergy and Immunology, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan 2 PRESTO, JST, Kawaguchi City, Saitama 332-0012, Japan 3 Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan
Correspondence to: M. Taniguchi, RIKEN Research Center for Allergy and Immunology, Department of Molecular Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail: mtaniguchi{at}faculty.chiba-u.jp
Transmitting editor: T. Watanabe
NKT cells expressing the invariant V
14 antigen receptor constitute a novel lymphocyte subpopulation with immunoregulatory functions. Stimulation via their invariant V
14 receptor with anti-CD3 or a ligand,
-galactosylceramide (
-GalCer), triggers activation of V
14 NKT cells, resulting in a rapid cytokine production such as IFN-
and IL-4. Soon after their receptor activation, V
14 NKT cells disappeared as judged by staining with CD1d tetramer loaded with
-GalCer (
-GalCer/CD1d tetramer), which has been believed to be due to apoptotic cell death. Here we show that such a disappearance was largely attributed to down-regulation of the V
14 receptor. In fact, V
14 NKT cells were relatively resistant to apoptosis compared to the conventional T cells as evidenced by less staining with Annexin-V, a limited DNA fragmentation, and their preferential expression of anti-apoptotic genes such as NAIP and MyD118. Furthermore, they did not become tolerant, and maintained their proliferative capacity and cytokine production even after their receptor down-regulation. These as yet unrecognized facets of V
14 NKT cells are discussed in relation to their regulatory functions.
Keywords:
-galactosylceramide, apoptosis, CD1d tetramer, cDNA array, cytokine production
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Gao, S. Radaeva, and O. Park Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases J. Leukoc. Biol., September 1, 2009; 86(3): 513 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. I. Iweala, D. W. Smith, K. S. Matharu, I. Sada-Ovalle, D. D. Nguyen, R. H. DeKruyff, D. T. Umetsu, S. M. Behar, and C. R. Nagler Vaccine-Induced Antibody Isotypes Are Skewed by Impaired CD4 T Cell and Invariant NKT Cell Effector Responses in MyD88-Deficient Mice J. Immunol., August 15, 2009; 183(4): 2252 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Parekh, S. Lalani, S. Kim, R. Halder, M. Azuma, H. Yagita, V. Kumar, L. Wu, and L. Van Kaer PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells J. Immunol., March 1, 2009; 182(5): 2816 - 2826. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawamura, K. Takeda, H. Kaneda, H. Matsumoto, Y. Hayakawa, D. H. Raulet, Y. Ikarashi, M. Kronenberg, H. Yagita, K. Kinoshita, et al. NKG2A Inhibits Invariant NKT Cell Activation in Hepatic Injury J. Immunol., January 1, 2009; 182(1): 250 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Diao, K. Iwabuchi, L. Li, K. Onoe, L. Van Kaer, S. Kon, Y. Saito, J. Morimoto, D. T. Denhardt, S. Rittling, et al. Osteopontin regulates development and function of invariant natural killer T cells PNAS, October 14, 2008; 105(41): 15884 - 15889. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Biburger and G. Tiegs Activation-induced NKT cell hyporesponsiveness protects from {alpha}-galactosylceramide hepatitis and is independent of active transregulatory factors J. Leukoc. Biol., July 1, 2008; 84(1): 264 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. F. Pedra, J. Mattner, J. Tao, S. M. Kerfoot, R. J. Davis, R. A. Flavell, P. W. Askenase, Z. Yin, and E. Fikrig c-Jun NH2-Terminal Kinase 2 Inhibits Gamma Interferon Production during Anaplasma phagocytophilum Infection Infect. Immun., January 1, 2008; 76(1): 308 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. McNab, D. G. Pellicci, K. Field, G. Besra, M. J. Smyth, D. I. Godfrey, and S. P. Berzins Peripheral NK1.1 NKT Cells Are Mature and Functionally Distinct from Their Thymic Counterparts J. Immunol., November 15, 2007; 179(10): 6630 - 6637. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Choi, T. Webb, M. Oelke, D. G. Scorpio, and J. S. Dumler Differential Innate Immune Cell Activation and Proinflammatory Response in Anaplasma phagocytophilum Infection Infect. Immun., June 1, 2007; 75(6): 3124 - 3130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zullo, K. Benlagha, A. Bendelac, and E. J. Taparowsky Sensitivity of NK1.1-Negative NKT Cells to Transgenic BATF Defines a Role for Activator Protein-1 in the Expansion and Maturation of Immature NKT Cells in the Thymus J. Immunol., January 1, 2007; 178(1): 58 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Harada, K. Magara-Koyanagi, H. Watarai, Y. Nagata, Y. Ishii, S. Kojo, S. Horiguchi, Y. Okamoto, T. Nakayama, N. Suzuki, et al. IL-21-induced B{varepsilon} cell apoptosis mediated by natural killer T cells suppresses IgE responses J. Exp. Med., December 25, 2006; 203(13): 2929 - 2937. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanagisawa, M. A. Exley, X. Jiang, N. Ohkochi, M. Taniguchi, and K.-i. Seino Hyporesponsiveness to Natural Killer T-Cell Ligand {alpha}-Galactosylceramide in Cancer-Bearing State Mediated by CD11b+ Gr-1+ Cells Producing Nitric Oxide Cancer Res., December 1, 2006; 66(23): 11441 - 11446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Motohashi, A. Ishikawa, E. Ishikawa, M. Otsuji, T. Iizasa, H. Hanaoka, N. Shimizu, S. Horiguchi, Y. Okamoto, S.-i. Fujii, et al. A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer Clin. Cancer Res., October 15, 2006; 12(20): 6079 - 6086. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Emoto, I. Yoshizawa, Y. Emoto, M. Miamoto, R. Hurwitz, and S. H. E. Kaufmann Rapid Development of a Gamma Interferon-Secreting Glycolipid/CD1d-Specific V{alpha}14+ NK1.1- T-Cell Subset after Bacterial Infection. Infect. Immun., October 1, 2006; 74(10): 5903 - 5913. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Brutkiewicz CD1d Ligands: The Good, the Bad, and the Ugly J. Immunol., July 15, 2006; 177(2): 769 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Larkin, G. J. Renukaradhya, V. Sriram, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells J. Immunol., July 1, 2006; 177(1): 268 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Svensson, S. Zubairi, A. Maroof, F. Kazi, M. Taniguchi, and P. M. Kaye Invariant NKT Cells Are Essential for the Regulation of Hepatic CXCL10 Gene Expression during Leishmania donovani Infection Infect. Immun., November 1, 2005; 73(11): 7541 - 7547. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yasunami, S. Kojo, H. Kitamura, A. Toyofuku, M. Satoh, M. Nakano, K. Nabeyama, Y. Nakamura, N. Matsuoka, S. Ikeda, et al. V{alpha}14 NK T cell-triggered IFN-{gamma} production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets J. Exp. Med., October 3, 2005; 202(7): 913 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Pellicci, K. J. L. Hammond, J. Coquet, K. Kyparissoudis, A. G. Brooks, K. Kedzierska, R. Keating, S. Turner, S. Berzins, M. J. Smyth, et al. DX5/CD49b-Positive T Cells Are Not Synonymous with CD1d-Dependent NKT Cells J. Immunol., October 1, 2005; 175(7): 4416 - 4425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kojo, K.-i. Seino, M. Harada, H. Watarai, H. Wakao, T. Uchida, T. Nakayama, and M. Taniguchi Induction of Regulatory Properties in Dendritic Cells by V{alpha}14 NKT Cells J. Immunol., September 15, 2005; 175(6): 3648 - 3655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Uldrich, N. Y. Crowe, K. Kyparissoudis, D. G. Pellicci, Y. Zhan, A. M. Lew, P. Bouillet, A. Strasser, M. J. Smyth, and D. I. Godfrey NKT Cell Stimulation with Glycolipid Antigen In Vivo: Costimulation-Dependent Expansion, Bim-Dependent Contraction, and Hyporesponsiveness to Further Antigenic Challenge J. Immunol., September 1, 2005; 175(5): 3092 - 3101. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang, T. Shimaoka, S. Kojo, M. Harada, H. Watarai, H. Wakao, N. Ohkohchi, S. Yonehara, M. Taniguchi, and K.-i. Seino Cutting Edge: Critical Role of CXCL16/CXCR6 in NKT Cell Trafficking in Allograft Tolerance J. Immunol., August 15, 2005; 175(4): 2051 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, K. Takeda, H. Akiba, Y. Hayakawa, K. Ogasawara, Y. Ikarashi, S. Miyake, H. Wakasugi, T. Yamamura, M. Kronenberg, et al. IFN-{gamma}-mediated negative feedback regulation of NKT-cell function by CD94/NKG2 Blood, July 1, 2005; 106(1): 184 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Bezbradica, A. K. Stanic, N. Matsuki, H. Bour-Jordan, J. A. Bluestone, J. W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce Distinct Roles of Dendritic Cells and B Cells in Va14Ja18 Natural T Cell Activation In Vivo J. Immunol., April 15, 2005; 174(8): 4696 - 4705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Duthie, M. Kahn, M. White, R. P. Kapur, and S. J. Kahn Both CD1d Antigen Presentation and Interleukin-12 Are Required To Activate Natural Killer T Cells during Trypanosoma cruzi Infection Infect. Immun., March 1, 2005; 73(3): 1890 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishikawa, S. Motohashi, E. Ishikawa, H. Fuchida, K. Higashino, M. Otsuji, T. Iizasa, T. Nakayama, M. Taniguchi, and T. Fujisawa A Phase I Study of {alpha}-Galactosylceramide (KRN7000)-Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1910 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schmieg, G. Yang, R. W. Franck, N. Van Rooijen, and M. Tsuji Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion PNAS, January 25, 2005; 102(4): 1127 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Parekh, A. K. Singh, M. T. Wilson, D. Olivares-Villagomez, J. S. Bezbradica, H. Inazawa, H. Ehara, T. Sakai, I. Serizawa, L. Wu, et al. Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct {alpha}- and {beta}-Anomeric Glycolipids J. Immunol., September 15, 2004; 173(6): 3693 - 3706. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pearson, P. Weiser, T. G. Markees, D. V. Serreze, L. S. Wicker, L. B. Peterson, A.-M. Cumisky, L. D. Shultz, J. P. Mordes, A. A. Rossini, et al. Islet Allograft Survival Induced by Costimulation Blockade in NOD Mice Is Controlled by Allelic Variants of Idd3 Diabetes, August 1, 2004; 53(8): 1972 - 1978. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sun, Z. Tian, S. Kulkarni, and B. Gao IL-6 Prevents T Cell-Mediated Hepatitis via Inhibition of NKT Cells in CD4+ T Cell- and STAT3-Dependent Manners J. Immunol., May 1, 2004; 172(9): 5648 - 5655. [Abstract] [Full Text] [PDF] |
||||








